Manufacturer

Country

Certificates

Registration Date	16 Nov 2016
Share

Xalkori

(0)

Medicine Pharmaceuticals Product Number : 0069-8141-20

Antineoplastic Agent

Drug Information

Generic

CRIZOTINIB

NDC Code

0069-8141-20

Drug Class

Multikinase inhibitors

Therapeutic Class

Antineoplastic Agent

Dosage form

Capsule

Route of Administration

Oral

Therapeutic Area

1.metastatic (cancer that has already spread) non-small cell lung cancer

Indication

XALKORI is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children.